The DOI matches its Crossref record; 1,258 of the 1,268 references it cites were found in a registry or an index.
Pharmacology and behavioral pharmacology of the mesocortical dopamine system
Abstract
The prefrontal cortex (PFC) has long been known to be involved in the mediation of complex behavioral responses. Considerable research efforts are directed towards refining the knowledge about the function of this brain area and the role it plays in cognitive performance and behavioral output. In the first part, this review provides, from a pharmacological perspective, an overview of anatomical, electrophysiological and neurochemical aspects of the function of the PFC, with an emphasis on the mesocortical dopamine system. Anatomy of the mesocortical system, basic physiological and pharmacological properties of neurotransmission within the PFC, and interactions between dopamine and glutamate as well as other transmitters within the mesocorticolimbic circuit are included. The coverage of these data is largely restricted to what is relevant for the second part of the review which focuses on behavioral studies that have examined the role of the PFC in a variety of phenomena, behaviors and paradigms. These include reward and addiction, locomotor activity and sensitization, learning, cognition, and schizophrenia. Although the focus of this review is on the mesocortical dopamine system, given the intricate interactions of dopamine with other transmitter systems within the PFC and the importance of the PFC as a source of glutamate in subcortical areas, these aspects are also covered in some detail where appropriate. Naturally, a topic as complex as this cannot be covered comprehensively in its entirety. Therefore this review is largely limited to data derived from studies using rats, and it is also specifically restricted to data concerning the medial PFC (mPFC). Since in several fields of research the findings concerning the function or role of the mPFC are relatively inconsistent, the question is addressed whether these inconsistencies might, at least in part, be related to the anatomical and functional heterogeneity of this brain area.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, in frontal cortex, because of low concentrations of the dopamine reuptake molecule DAT, it takes much longer to clear dopamine from synapses (for reviews, see, e.g., [72–74]).”
From Cortical and basal ganglia contributions to habit learning and automaticity (2010) · cites this paper as [72]
Citations
Cites
Plum, F. (1960) · Archives of Neurology · doi:10.1001/archneur.1960.03840090124020 · Cited by 10,388
A neural substrate of prediction and reward
Schultz, W., Dayan, P., & Montague, P. R. (1997) · Science · doi:10.1126/science.275.5306.1593 · Cited by 9,388
Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
Handbook of Chemical Neuroanatomy
Stern, C. D. (1986) · Neurochemistry International · doi:10.1016/0197-0186(86)90021-5 · Cited by 4,160
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Morris, R. G. M., Anderson, E., Lynch, G. S., & Baudry, M. (1986) · Nature · doi:10.1038/319774a0 · Cited by 3,640
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
The somatic marker hypothesis and the possible functions of the prefrontal cortex
Damasio, A. R. (1996) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1996.0125 · Cited by 2,847
Research works printed but not linked: 50
- Arvanitogiannis, 1997, Fos expression following self-stimulation of the medial prefrontal cortex, Soc. Neurosci. Abstr., 23, 2384
- Bauco, 1994, Extracellular nucleus accumbens dopamine and metabolite levels during earned and unearned lateral hypothalamic brain stimulation, Soc. Neurosci. Abstr., 20, 823
- Carr, G.D., Fibiger, H.C., Phillips, A.G., 1989. Conditioned place preference as a measure of drug reward. In: J.M. Liebman, S.J. Cooper (Eds.), The Neuropharmacological Basis of Reward. Clarendon Press, Oxford, pp. 264–319.
- Carter, 1980, Glutamatergic pathways from the medial pre-frontal cortex to the anterior striatum, nucleus accumbens and substantia nigra, Br. J. Pharmacol., 70, 50
- Carter, 1978, Studies on the roles of catecholamines in the frontal cortex, Br. J. Pharmacol., 62, 402P
- Childress, 1996, Brain correlates of cue-induced and opiate craving, Soc. Neurosci. Abstr., 22, 365.5
- Conover, 1992, Coactivation of the lateral hypothalamus and ventral tegmental area yields greater reward summation than coactivation of the lateral hypothalamus and medial pre-frontal cortex, Soc. Neurosci. Abstr., 18, 709
- Di Chiara, 1992, Heterologous monoamine uptake: lack of transmitter specificity of neuron-specific carriers, Neurochem. Int., 20, 231S
- Ditzler, 1991, Efficacy and tolerability of memantine in patients with dementia syndrome, Arzneimittelforschung/Drug Res., 8, 773
- Douglin, 1979, Gradual increases in self-stimulation response rates: effect of electrode loci, Physiol. Behav., 7, 135
- Feenstra, 1993, In vivo dopamine release in the rat prefrontal cortex is increased by stimulation of mediodorsal thalamic nucleus, Soc. Neurosci. Abstr., 19, 1382
- Feenstra, 1995, Local application of a competitive NMDA antagonist in the medial prefrontal cortex increases in vivo DA but not NA release, Br. J. Pharmacol., 114, 328P
- Forno, L.S., 1990. Pathology of Parkinson's disease: the importance of the substantia nigra and Lewy bodies. In: Stern, G. (Ed.), Parkinson's Disease. Chapman and Hall, London, pp. 185–238.
- Fuster, J., 1980. The prefrontal cortex. Raven Press, New York.
- Gabbott, 1996, Local circuit neurons in the medial prefrontal cortex (areas 24a,b,c, 25 and 32) in the monkey: II. Quantitative arial and laminar distributions, J. Comp. Neurol., 364, 609, 10.1002/(SICI)1096-9861(19960122)364:4<609::AID-CNE2>3.0.CO;2-7 · DOI
- Gillham, 1990, GABA neurons in the ventral tegmental area project to the medial prefrontal cortex: a non-dopaminergic mesocortical system, Soc. Neurosci. Abstr., 16, 105
- Grace, 1984, Electrophysiology and morphology of four classes of prefrontal neocortical neurons studied in vitro, Soc. Neurosci. Abstr., 10, 739
- Gresch, 1995, Stress-induced sensitization of dopamine and norepinephrine efflux in medial prefrontal cortex of the rat, J. Neurochem., 65, 575, 10.1046/j.1471-4159.1995.65010111.x · DOI
- Hemby, 1990, Neuropharmacological assessment of cocaine-induced conditioned place preference using intra-cranial microinjections, Soc. Neurosci. Abstr., 16, 243.6
- Hoffmann, 1986, Multiple effects of neuronal uptake inhibitors on transmitter release, J. Pharmacol. Exp. Ther., 238, 437
- Koob, G.F., Goeders, N.E., 1989. Neuroanatomical substrates of drug self-administration. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 214–236.
- Kuczenski, R., Segal, D.S., 1994. Neurochemistry of amphetamine. In: Cho, A., Segal, D.S. (Eds.), Amphetamine and its analogs. Academic Press, San Diego, pp. 81–113.
- Kurata, 1993, Differential effects of tight and loose 2-h restraint stress on extracellular concentrations of dopamine in nucleus accumbens and anteromedial frontal cortex, Jpn. J. Psychiatry Neurol., 47, 57
- Lindvall, O., Björklund, A., 1984. In: Descarries, L., Reader, T.R., Jasper, H.H. (Eds.), General organization of cortical monoamine systems. Liss, New York.
- Lu, 1997, Expression of D1 receptor mRNA in projections from the forebrain to the ventral tegmental area, Synapse, 25, 205, 10.1002/(SICI)1098-2396(199702)25:2<205::AID-SYN11>3.0.CO;2-X · DOI
- Moore, 1996, Interactions between amygdala and prefrontal cortical afferents to the nucleus accumbens and their modulation by dopamine receptor activation, Soc. Neurosci. Abstr., 22, 1088
- Moore, R.Y., Card, J.P., 1984. Noradrenaline-containing neuron systems. In: Björklund, A., Hökfelt, T. (Eds.), Handbook of Chemical Neuroanatomy, vol. 2. Elsevier, Amsterdam, pp. 123–156.
- Muly, 1997, D1 dopamine receptors are present in parvalbumine-positive interneurons in macaque prefrontal cortex, Soc. Neurosci. Abstr., 23, 1772
- Nishijima, 1996, Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis, Synapse, 22, 304, 10.1002/(SICI)1098-2396(199604)22:4<304::AID-SYN2>3.0.CO;2-F · DOI
- Nonneman, 1974, Comparisons of behavioral effects of hippocampal and prefrontal cortex lesions in the rat, J. Comp. Physiol. Psychol., 87, 249, 10.1037/h0036864 · DOI
- Palkovits, M., 1979. Dopamine levels of individual brain regions: biochemical aspects of DA distribution in the central nervous system. Academic Press, London, pp. 343–356.
- Phillips, A.G., Fibiger, H.C., 1989. Neuroanatomical bases of intracranial self-stimulation: untangling the Gordian knot. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 66–105.
- Pickel, V.M., Sesack, S.M., 1995. Electron microscopy of central dopamine systems. In: Bloom, F.E., Kupfer, D.J. (Eds.), Psychopharmacology: The fourth generation of progress. Raven Press, New York, pp. 257–268.
- Seamans, 1995, Selective impairment on a delayed radial arm task following local administration of a D1, but not a D2, antagonist into the prefrontal cortex, Soc. Neurosci. Abstr., 21, 1942
- Shibata, 1990, Effect of dopamine agonists on locomotor activity of anteromedial frontal cortex lesioned rats, Jpn. J. Psychiatry Neurol., 44, 789
- Shippenberg, 1993, Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D1 versus D2 dopamine receptors, J. Pharmacol. Exp. Ther., 265, 53
- Simon, 1981, Dopaminergic A10 neurons and the frontal system, J. Physiol., 77, 81
- Smiley, 1996, Serotonergic axons in monkey prefrontal cerebral cortex synapse predominantly on interneurons as demonstrated by serial section electron microscopy, J. Comp. Neurol., 367, 431, 10.1002/(SICI)1096-9861(19960408)367:3<431::AID-CNE8>3.0.CO;2-6 · DOI
- Smith, 1998, Microcircuitry of the direct and indirect pathways of the basal ganglia, Neuroscience, 86, 353
- Stellar, J.R., Rice, M.B., 1989. Pharmacological basis of intracranial self-stimulation reward. In: Liebman, J.M., Cooper, S.J. (Eds.), The neuropharmacological basis of reward. Clarendon Press, Oxford, pp. 14–65.
- Taylor, 1978, Comparison of monoamine uptake by cocaine, methylphenidate and amphetamine, Res. Commun. Pathol. Pharmacol., 21, 67
- Thierry, A.M., Tassin, J.P., Blanc, G., Glowinski, J., 1976b. Topographical and pharmacological study of the mesocortical dopaminergic systems. In: Wauqnier, A., Rolls, E.T. (Eds.), Brain Stimulation Reward. North-Holland, Amsterdam, pp. 290–293.
- Tzschentke, 1997, Electrical stimulation of the medial prefrontal cortex elicits release of dopamine and glutamate in nucleus accumbens and ventral tegmental area in rats: effects of different frequencies and currents, Soc. Neurosci. Abstr., 23, 1753
- Tzschentke, T.M., Schmidt, W.J., 1998b. Functional heterogeneity of the medial prefrontal cortex and its relevance for drug reward. On-line Proceedings of the Fifth Internet World Congress on Biomedical Sciences (INABIS)’ 98 at McMaster University, Canada (available from URL: http://www.mcmaster.ca/inabis98/).
- Uylings, H.B.M., van Eden, C.G., De Bruin, J.P.C., Corner, M.A., Feenstra, M.G.P. (Eds.), 1990. The prefrontal cortex—its structure, function and pathology. Progress in Brain Research, vol. 85. Elsevier, Amsterdam.
- van Eden, 1997, Efferents from the rat medial prefrontal cortex can influence dopaminergic cells in the ventral tegmental area, which project to the nucleus accumbens, Soc. Neurosci. Abstr., 23, 1213
- Weiner, 1990, Disruption of latent inhibition by a low dose of amphetamine is antagonised by haloperidol and apomorphine, J. Psychopharmacol., 4, 255
- White, F.J., Wachtel, S.R., Johansen, P.A., Einhorn, L.C., 1987. Electrophysiological studies of the rat mesoaccumbens dopamine systems: focus on dopamine receptor subtypes, interactions, and the effect of cocaine. In: Chiodo, L.A., Freeman, F.A. (Eds.), Neurophysiology of dopaminergic systems: current status and clinical perspectives. Lakeshore, Detroit, pp. 317–365.
- White, F.J., Hu, X.T., Henry, D.J., Zhang, X.F., 1995a. Neurophysiological alterations in the mesocorticolimbic dopamine system with repeated cocaine administration. In: Hammer Jr, R.P. (Ed.), The Neurobiology of Cocaine: Cellular and Molecular Mechanisms. CRC Press, Boca Raton, FL, pp. 99–119.
- Yang, 1996, Focal dendritic D1 receptor stimulation differentially modulates layers I-II and V-VI glutamate inputs to deep layer prefrontal cortical pyramidal neurons in vitro, Soc. Neurosci. Abstr., 22, 1770
Cited by
Sorted by citations
The principal features and mechanisms of dopamine modulation in the prefrontal cortex
Seamans, J. K., & Yang, C. R. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.05.006 · Cited by 1,592
Antidepressant Actions of Histone Deacetylase Inhibitors
Covington, H. E., Maze, I., LaPlant, Q. C., Vialou, V. F., Ohnishi, Y. N., Berton, O., Fass, D. M., Renthal, W., Rush, A. J., Wu, E. Y., et al. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.1758-09.2009 · Cited by 624
Alcaro, A., Huber, R., & Panksepp, J. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.07.014 · Cited by 661
Dopamine: a potential substrate for synaptic plasticity and memory mechanisms
Jay, T. M. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00085-6 · Cited by 579
Regulation of affect by the lateral septum: implications for neuropsychiatry
Sheehan, T. P., Chambers, R. A., & Russell, D. S. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.009 · Cited by 514
Mesolimbic dopaminergic pathways in fear conditioning
Pezze, M. A., & Feldon, J. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.004 · Cited by 519
Cortical and basal ganglia contributions to habit learning and automaticity
Ashby, F. G., Turner, B. O., & Horvitz, J. C. (2010) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2010.02.001 · Cited by 481
Mechanism of Action of Atypical Antipsychotic Drugs and the Neurobiology of Schizophrenia
Horáček, J., Bubeníková‐Valešová, V., Kopeček, M., Páleníček, T., Dockery, C. A., Mohr, P., & Höschl, C. (2006) · CNS Drugs · doi:10.2165/00023210-200620050-00004 · Cited by 467
Opponency revisited: competition and cooperation between dopamine and serotonin
Boureau, Y.-L., & Dayan, P. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.151 · Cited by 456
Cellular and synaptic mechanisms of nicotine addiction
Mansvelder, H. D., & McGehee, D. S. (2002) · Journal of Neurobiology · doi:10.1002/neu.10148 · Cited by 450
Cellular mechanisms of nicotine addiction
Dani, J. A., & De Biasi, M. (2001) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00652-9 · Cited by 408
Neuhoff, H., Neu, A. D., Liss, B., & Roeper, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-04-01290.2002 · Cited by 400
Weiner, I. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1313-x · Cited by 398
Computational perspectives on dopamine function in prefrontal cortex
Cohen, J. D., Braver, T. S., & Brown, J. W. (2002) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(02)00314-8 · Cited by 387
Linking genes to brain, behavior and neurological diseases: what can we learn from zebrafish?
Guo, S. (2003) · Genes Brain & Behavior · doi:10.1046/j.1601-183x.2003.00053.x · Cited by 369
Anatomical Substrates for Glutamate‐Dopamine Interactions
Sesack, S. R., CARR, D. B., Omelchenko, N., & Pinto, A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.066 · Cited by 372
Neurobiology of Dopamine in Schizophrenia
Guillin, O., Abi‐Dargham, A., & Laruelle, M. (2007) · International Review of Neurobiology · doi:10.1016/s0074-7742(06)78001-1 · Cited by 365
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Goldwater, D. S., Pavlides, C., Hunter, R. G., Bloss, E. B., Hof, P. R., McEwen, B. S., & Morrison, J. H. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.08.053 · Cited by 333
Léna, I., Parrot, S., Deschaux, O., Muffat‐Joly, S., Sauvinet, V., Renaud, B., Suaud‐Chagny, M. ‐., & Gottesmann, C. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20602 · Cited by 322
Ashby, F. G., & Maddox, W. T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05874.x · Cited by 355
The many faces of fatigue in major depressive disorder
Demyttenaere, K., De Fruyt, J., & Stahl, S. M. (2005) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145704004729 · Cited by 288
Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia
Abi‐Dargham, A., & Moore, H. M. (2003) · The Neuroscientist · doi:10.1177/1073858403252674 · Cited by 279
Zheng, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.001 · Cited by 268
Glutamatergic mechanisms in addiction
Tzschentke, T., & Schmidt, W. (2003) · Molecular Psychiatry · doi:10.1038/sj.mp.4001269 · Cited by 277
Self-citationHippocampal modulation of sensorimotor processes
Bast, T., & Feldon, J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00112-6 · Cited by 264
Monoamine transporters and psychostimulant addiction
Howell, L. L., & Kimmel, H. L. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.003 · Cited by 254
The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders
Dobryakova, E., Genova, H. M., DeLuca, J., & Wylie, G. R. (2015) · Frontiers in Neurology · doi:10.3389/fneur.2015.00052 · Cited by 242
Selective prefrontal cortex inputs to dopamine cells: implications for schizophrenia
Sesack, S. R., & CARR, D. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00931-9 · Cited by 238
Puig, M. V. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh104 · Cited by 232
Congdon, E., Lesch, K. P., & Canli, T. (2008) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30557 · Cited by 218
Meyer, U., Nyffeler, M., Schwendener, S., Knuesel, I., Yee, B. K., & Feldon, J. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301413 · Cited by 220
Optogenetic dissection of medial prefrontal cortex circuitry
Riga, D., Matos, M. R., Glas, A., Smit, A. B., Spijker, S., & Van den Oever, M. C. (2014) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2014.00230 · Cited by 208
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Shen, H., Hagino, Y., Kobayashi, H., Shinohara-Tanaka, K., Ikeda, K., Yamamoto, H., Yamamoto, T., Lesch, K., Murphy, D. L., Hall, F. S., et al. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300476 · Cited by 204
Lindgren, N., Usiello, A., Goiny, M., Haycock, J. W., Erbs, E., Greengard, P., Hökfelt, T. G. M., Borrelli, E., & Fisone, G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0730708100 · Cited by 203
Stahl, S. M., Zhang, L., Damatarca, C., & Grady, M. M. (2003) · PubMed · Cited by 202
Arco, A. D., & Mora, F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0243-8 · Cited by 211
The WAG/Rij strain: A genetic animal model of absence epilepsy with comorbidity of depressiony
Sarkisova, K. Y., & van Luijtelaar, G. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.11.010 · Cited by 206
Alcohol and the prefrontal cortex
Abernathy, K., Chandler, L. J., & Woodward, J. J. (2010) · International Review of Neurobiology · doi:10.1016/s0074-7742(10)91009-x · Cited by 196
Development of alcohol-associated cues and cue-induced brain activation in alcoholics
Wrase, J., Grüsser, S. M., Vollstädt‐Klein, S., Diener, C., Hermann, D., Flor, H., Mann, K. F., Braus, D. F., & Heinz, A. (2002) · European Psychiatry · doi:10.1016/s0924-9338(02)00676-4 · Cited by 192
Lubow, R. E. (2005) · Schizophrenia Bulletin · doi:10.1093/schbul/sbi005 · Cited by 192
Dopamine and Glutamate in Huntington's Disease: A Balancing Act
André, V. M., Cepeda, C., & Levine, M. S. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00134.x · Cited by 194
Adell, A., & Artigas, F. (2004) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2004.05.001 · Cited by 197
Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats
Shoblock, J. R., Sullivan, E. B., Maisonneuve, I. M., & Glick, S. D. (2003) · Psychopharmacology · doi:10.1007/s00213-002-1288-7 · Cited by 181
Klauss, J., Penido Pinheiro, L. C., Silva Merlo, B. L., Correia Santos, G. D. A., Fregni, F., Nitsche, M. A., & Miyuki Nakamura-Palacios, E. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000984 · Cited by 178
Perrotti, L. I., Bolaños, C. A., Choi, K., Russo, S. J., Edwards, S., Ulery, P. G., Wallace, D. L., Self, D. W., Nestler, E. J., & Barrot, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04110.x · Cited by 178
Cannabinoids and prefrontal cortical function: Insights from preclinical studies
Egerton, A., Allison, C., Brett, R. R., & Pratt, J. A. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.12.002 · Cited by 177
Del Arco, A., & Mora, F. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.04.011 · Cited by 163
Prefrontal cortex plasticity mechanisms in drug seeking and relapse
van den Oever, M. C., Spijker, S., Smit, A. B., & Vries, T. J. D. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2009.11.016 · Cited by 172
The activation of interactive attentional networks
Xuan, B., Mackie, M., Spagna, A., Wu, T., Tian, Y., Hof, P. R., & Fan, J. (2016) · NeuroImage · doi:10.1016/j.neuroimage.2016.01.017 · Cited by 157
The influence of mental fatigue and motivation on neural network dynamics; an EEG coherence study
Lorist, M. M., Bezdan, E., ten Caat, M., Span, M. M., Roerdink, J. B. T. M., & Maurits, N. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.03.015 · Cited by 158
The neurobiology of methamphetamine induced psychosis
Hsieh, J. H., Stein, D. J., & Howells, F. M. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00537 · Cited by 160
Fatigue in Liver Disease: Pathophysiology and Clinical Management
Swain, M. G. (2006) · Canadian Journal of Gastroenterology · doi:10.1155/2006/624832 · Cited by 148
Aransay, A., Rodríguez-López, C., García‐Amado, M., Clascá, F., & Prensa, L. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00059 · Cited by 153
Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy
Cordato, N. J., Duggins, A., Halliday, G. M., Morris, J. G., & Pantelis, C. (2005) · Brain · doi:10.1093/brain/awh508 · Cited by 146
Effects of medial prefrontal cortex cytotoxic lesions in mice
Deacon, R. M. J., Penny, C., & Rawlins, J. N. P. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00225-5 · Cited by 143
Feduccia, A. A., Chatterjee, S., & Bartlett, S. E. (2012) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2012.00083 · Cited by 151
Environmental enrichment, prefrontal cortex, stress, and aging of the brain
Segovia, G., Arco, A. D., & Mora, F. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0214-0 · Cited by 140
Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents
Straub, C., Tritsch, N. X., Hagan, N. A., Gu, C., & Sabatini, B. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0589-14.2014 · Cited by 130
Dong, Y., Nasif, F. J., Tsui, J. J., Ju, W. Y. H., Cooper, D., Hu, X., Malenka, R. C., & White, F. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4715-04.2005 · Cited by 129
Neurotensin: Role in psychiatric and neurological diseases
Cáceda, R., Kinkead, B. L., & Nemeroff, C. B. (2006) · Peptides · doi:10.1016/j.peptides.2006.04.024 · Cited by 129
Omelchenko, N., & Sesack, S. R. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20852 · Cited by 127
Novel Approaches to the Treatment of Cocaine Addiction
Sofuoglu, M., & Kosten, T. R. (2005) · CNS Drugs · doi:10.2165/00023210-200519010-00002 · Cited by 126
A SPECT study of apathy in Alzheimer's disease
Lanctôt, K. L., Moosa, S., Herrmann, N., Leibovitch, F. S., Rothenburg, L., Cotter, A., & Black, S. E. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000103633 · Cited by 126
Aripiprazole, A Drug that Displays Partial Agonism and Functional Selectivity
Tuplin, E. W. N., & Holahan, M. R. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170413115754 · Cited by 131
Milesi‐Hallé, A., McMillan, D. E., Laurenzana, E. M., Byrnes-Blake, K. A., & Owens, S. M. (2007) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2006.12.018 · Cited by 124
The neural circuitry of reward and its relevance to psychiatric disorders
Chau, D. T., Roth, R. M., & Green, A. I. (2004) · Current Psychiatry Reports · doi:10.1007/s11920-004-0026-8 · Cited by 123
Tang, J., Qu, C., & Huo, F. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.10.002 · Cited by 121
Cholinergic connectivity: it's implications for psychiatric disorders
Scarr, E., Gibbons, A. S., Neo, J. H., Udawela, M., & Dean, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00055 · Cited by 124
Managò, F., Mereu, M., Mastwal, S. S., Mastrogiacomo, R., Scheggia, D., Emanuele, M., Luca, M. A. D., Weinberger, D. R., Wang, K. H., & Papaleo, F. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.044 · Cited by 119
Mixing pleasures: Review of the effects of drugs on sex behavior in humans and animal models
Frohmader, K. S., Pitchers, K. K., Balfour, M. E., & Coolen, L. M. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.11.009 · Cited by 121
Kheramin, S., Body, S., Ho, M.-Y., Vel�zquez-Martinez, D. N., Bradshaw, C. M., Szabadi, E., Deakin, J. F. W., & Anderson, I. M. (2004) · Psychopharmacology · doi:10.1007/s00213-004-1813-y · Cited by 117
Naef, L., Srivastava, L. K., Gratton, A. P., Hendrickson, H. P., Owens, S. M., & Walker, C. (2007) · Psychopharmacology · doi:10.1007/s00213-007-1008-4 · Cited by 119
Revel, F. G., Meyer, C. A., Bradaïa, A., Jeanneau, K., Calcagno, E., André, C. B., Hänggi, M., Miss, M.-T., Galley, G., Norcross, R. D., et al. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.109 · Cited by 114
Baranwal, A., & Chandra, P. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.09.002 · Cited by 115
Role of the mesotelencephalic dopamine system in learning and memory processes in the rat
Hefco, V., Yamada, K., Hefco, A., Hriţcu, L., Tiron, A., & Nabeshima, T. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)02115-0 · Cited by 115
Pistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.10.002 · Cited by 120
Dong, Y., & White, F. J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02686.2003 · Cited by 112
Congdon, E. L., & Canli, T. (2005) · Behavioral and Cognitive Neuroscience Reviews · doi:10.1177/1534582305285980 · Cited by 109
Estrogen regulates responses of dopamine neurons in the ventral tegmental area to cocaine
Zhang, D., Yang, S., Yang, C., Jin, G.-Z., & Zhen, X. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1188-6 · Cited by 119
Takahashi, Y., Mizuo, K., Shinkai, Y., Oshio, S., & Takeda, K. (2010) · The Journal of Toxicological Sciences · doi:10.2131/jts.35.749 · Cited by 108
Nasif, F. J., Hu, X., & White, F. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0010-05.2005 · Cited by 107
Homberg, J. R., Akker, M. V. D., Raasø, H. S., Wardeh, G., Binnekade, R., Schoffelmeer, A. N. M., & Vries, T. J. D. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.01976.x · Cited by 106
Riegel, A. C., Zapata, A. G., Shippenberg, T. S., & French, E. D. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301273 · Cited by 105
Möller, M., du Preez, J. L., Emsley, R. A., & Harvey, B. H. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.09.006 · Cited by 103
Meyer, U., & Feldon, J. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1504-9 · Cited by 103
Nasif, F. J., Sidiropoulou, K., Hu, X., & White, F. J. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075184 · Cited by 100
Young, K. A., Liu, Y., Gobrogge, K. L., Wang, H., & Wang, Z. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4275-13.2014 · Cited by 99
Dazzi, L., Seu, E., Cherchi, G., Barbieri, P. P., Matzeu, A., & Biggio, G. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301150 · Cited by 103
Miller, A. D., & Blaha, C. D. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04017.x · Cited by 93
The basal ganglia: anatomy, physiology, and pharmacology
Tisch, S. H., Silberstein, P., Limousin, P. D., & Jahanshahi, M. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.06.004 · Cited by 96
Cannabis, Cannabinoids and Schizophrenia: Integration of the Evidence
Cohen, M. A., Solowij, N., & Carr, V. J. (2008) · Australian & New Zealand Journal of Psychiatry · doi:10.1080/00048670801961156 · Cited by 90
Associative deficit accounts of disrupted latent inhibition and blocking in schizophrenia
Escobar, M. E., Oberling, P., & Miller, R. R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00067-7 · Cited by 90
Dopaminergic Modulation of Auditory Cortex-Dependent Memory Consolidation through mTOR
Schicknick, H., Schott, B. H., Budinger, E., Smalla, K., Riedel, A., Seidenbecher, C. I., Scheich, H., Gundelfinger, E. D., & Tischmeyer, W. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn026 · Cited by 88
Efficacy and Safety of Varenicline for Smoking Cessation
Hays, J. T., Ebbert, J. O., & Sood, A. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.01.017 · Cited by 84
Nakamura-Palacios, E. M., Lopes, I. B. C., Souza, R. A., Klauss, J., Batista, E. K., Conti, C. L., Moscon, J. A., & de Souza, R. S. M. (2016) · Journal of Neural Transmission · doi:10.1007/s00702-016-1559-9 · Cited by 88
Arco, A. D., Segovia, G., Canales, J. J., GARRIDO, P., de Blas, M., García‐Verdugo, J. M., & Mora, F. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0565-8 · Cited by 85
Leng, A., Feldon, J., & Ferger, B. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.011 · Cited by 83
Huang, C., Lin, H., & Hsu, K. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhl096 · Cited by 83
Metadata
- Authors
- Tzschentke, T. M.
- Affiliations
- Grünenthal Group (Germany) (DE)
- Corresponding author
- Tzschentke, T.M.
- ORCID
- Tzschentke, T.M.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2001-02
- Volume
- 63
- Issue
- 3
- Pages
- 241-320
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2111304405
- Semantic Scholar
- 314205aef63746557803f0214ed764321bbe28dc
- Cited by
- 481
- References
- 1,268
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 9 · 2023: 19 · 2022: 7 · 2021: 6 · 2020: 8 · 2019: 13 · 2018: 6 · 2017: 17 · 2016: 14 · 2015: 24 · 2014: 21 · 2013: 11 · 2012: 24
- FWCI
- 2.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neurobiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- mesocortical dopamine system, prefrontal cortex, medial prefrontal cortex, glutamate, dopamine-glutamate interaction, mesocorticolimbic circuit, reward, addiction, locomotor activity, sensitization, learning, cognition, schizophrenia
- MeSH terms
- Animals, Behavior, Animal, Dopamine, Humans, Synaptic Transmission, Neurons, Prefrontal Cortex, Ventral Tegmental Area
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review